- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
NeuroDerm, Novavax and Nektar Therapeutics were among the biotech stock movers in premarket trading on July 24.
Wall Street's first glimpse at the second quarter.
There are five over-tenured directors and four directors with whom CEO Ginni Rometty works with outside of the company, according to BoardEx.